GSI 7977 (Sovaldi 400 mg)

Generic Name: sofosbuvir

Pill imprint GSI 7977 has been identified as Sovaldi 400 mg.

Sovaldi is used in the treatment of hepatitis c and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GSI 7977

Sovaldi 400 mg GSI 7977
Sovaldi
Generic Name:
sofosbuvir
Imprint:
GSI
7977
Strength:
400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)